Cystic fibrosis and portal hypertension: Distal splenorenal shunt can prevent the need for future liver transplant

This study evaluates distal splenorenal shunt (DSRS) as an alternative to liver transplantation for managing portal hypertension in children with cystic fibrosis and compensated cirrhosis. Between 2008-2017, five CF patients underwent DSRS while nine with decompensated disease received transplants, demonstrating DSRS as a viable bridge therapy.